Eigen Therapeutics Raises $7M in Seed Funding

Eigen Therapeutics, a Redwood Metropolis, CA-based oncology biotech startup, raised $7M in Seed funding.

The spherical was led by Josh Kopelman with participation from Builders VC, Kevin Mahaffey, Hawktail, Matthew De Silva, Varsha Rao, Bioverge, Alumni Ventures, and Mount Nice Ventures.

The corporate intends to make use of the funds to use their novel high-throughput platform towards the event of priming therapies. Their preliminary applications are centered on hematological malignancies; sooner or later, their platform will enable them to spin up applications for different most cancers indications, corresponding to stable tumors.

Based by an engineer and a scientist, Transon Nguyen and Kamran Ali, Eigen is concentrated on the event of “priming” therapies, therapies that assist focused therapies attain their full potential by addressing most cancers heterogeneity, making most cancers cells extra susceptible and/or making wholesome cells extra resilient to remedy. The corporate takes a two-step strategy to treating most cancers. Step one is a priming remedy, which primarily shines a highlight on the most cancers cells to make them extra recognizable. They do that by growing goal expression throughout most cancers cells.

Shishir Gupta, The Founder & CEO of StartupLanes said,

Eigen Therapeutics Raises $7M in Seed Funding. May this new business bring you huge success and fulfillment.

About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.

Startups looking for funding may apply through?StartupLanes Funding Application.